Skip to content

Clark Hill Advises HCW Biologics on $1.5 Million At-the-Market Follow-On Offering

February 23, 2026

Clark Hill’s Capital Markets team, led by Jim Groth and Jeny Zarmon, served as issuer’s counsel to HCW Biologics, Inc. (Nasdaq: HCWB) in its $1.5 million follow-on offering priced at-the-market under Nasdaq rules, consisting of common stock (or pre-funded warrants) with accompanying warrants.

Related Practice Areas

Subscribe for the latest

Subscribe

Related

Legal Updates

New Illinois Landlord Fee Transparency Requirements Take Effect in 2027

Illinois landlords face new fee disclosure rules in 2027, including a $50 application fee cap and restrictions on lease, maintenance, and other charges.

Explore more
Legal Updates

What Your Company Should Consider about Tariff Policy After the Midterms

Tariff relief could become more viable for U.S. importers. Learn what Congress and the Trump administration could change and what companies should do to prepare now.

Explore more
Legal Updates

AI in Attorney Fee Petitions: Tenth Circuit Rules AI Use Alone Won’t Reduce a Fee Award

Tenth Circuit rules in Flux Drive that AI use alone does not justify cutting attorney fee awards without evidence that the hours billed were unreasonable or excessive.

Explore more

The Clark Hill approach is equally pragmatic and growth-minded, which is why we understand our clients’ toughest business challenges. Our multidisciplinary, global team of advisors focuses on smart legal solutions, delivered simply.

© 2026 Clark Hill PLC.